欧洲ANCA相关性血管炎登记数据库的数据质量与患者特征:基于联邦查询的数据检索
该研究通过构建血管炎特异性本体并采用SPARQL联邦查询,整合六个欧洲ANCA相关性血管炎登记数据库共5282例患者,评估数据质量并描述患者特征、治疗与结局;唯一性和数据类型一致性均为100%,完整性和正确性分别为49%-100%和60%-100%,结局率通过随机效应Meta分析评估。
要点
- 六个欧洲ANCA相关性血管炎登记数据库经语义网技术联邦整合,共识别5282例患者。
- 唯一性和数据类型一致性在所有评估变量中均为100%,完整性和正确性分别为49%-100%和60%-100%。
- 静脉环磷酰胺用于缓解诱导治疗982例(50.7%),利妥昔单抗505例(17.7%)。
核心结论
- 在迄今报告的最大ANCA相关性血管炎队列研究中,研究者利用语义网技术联邦整合患者登记数据库,并强调了对数据质量的担忧。
- 患者特征、治疗和结局的比较因招募设置异质而受限。
研究设计与样本
- 通过创建血管炎特异性Findable、Accessible、Interoperable、Reusable、VASCulitis本体,对六个联邦ANCA相关性血管炎登记数据库进行 harmonisation 并实现语义互操作。
- 从唯一性、一致性、完整性和正确性四个维度评估数据质量,使用SPARQL检索汇总数据,结局率通过随机效应Meta分析评估。
主要发现
- 共识别5282例ANCA相关性血管炎病例,其中肉芽肿性多血管炎2754例(52.1%)、显微镜下多血管炎1580例(29.9%)、嗜酸性肉芽肿性多血管炎937例(17.7%)。
- 器官受累模式包括肺3281例(65.1%)、耳鼻喉2860例(56.7%)、肾2534例(50.2%)。
- 静脉环磷酰胺用于缓解诱导治疗982例(50.7%),利妥昔单抗505例(17.7%),静脉脉冲糖皮质激素使用比例变异很大(11%-91%)。
- 总体死亡率和终末期肾病发生率分别为每1000患者年28.8(95%CI 19.7至42.2)和24.8(95%CI 19.7至31.1)。
关键数值与推荐
- 唯一性和数据类型一致性在所有评估变量中均为100%,完整性和正确性分别范围为49%-100%和60%-100%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 患者特征、治疗和结局的比较因招募设置异质而受限。
- 原文强调了对数据质量的担忧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to describe the data structure and harmonisation process, explore data quality and define characteristics, treatment, and outcomes of patients across six federated antineutrophil cytoplasmic antibody-associated vasculitis (AAV) registries. METHODS: Through creation of the vasculitis-specific Findable, Accessible, Interoperable, Reusable, VASCulitis ontology, we harmonised the registries and enabled semantic interoperability. We assessed data quality across the domains of uniqueness, consistency, completeness and correctness. Aggregated data were retrieved using the semantic query language SPARQL Protocol and Resource Description Framework Query Language (SPARQL) and outcome rates were assessed through random effects meta-analysis. RESULTS: A total of 5282 cases of AAV were identified. Uniqueness and data-type consistency were 100% across all assessed variables. Completeness and correctness varied from 49%-100% to 60%-100%, respectively. There were 2754 (52.1%) cases classified as granulomatosis with polyangiitis (GPA), 1580 (29.9%) as microscopic polyangiitis and 937 (17.7%) as eosinophilic GPA. The pattern of organ involvement included: lung in 3281 (65.1%), ear-nose-throat in 2860 (56.7%) and kidney in 2534 (50.2%). Intravenous cyclophosphamide was used as remission induction therapy in 982 (50.7%), rituximab in 505 (17.7%) and pulsed intravenous glucocorticoid use was highly variable (11%-91%). Overall mortality and incidence rates of end-stage kidney disease were 28.8 (95% CI 19.7 to 42.2) and 24.8 (95% CI 19.7 to 31.1) per 1000 patient-years, respectively. CONCLUSIONS: In the largest reported AAV cohort-study, we federated patient registries using semantic web technologies and highlighted concerns about data quality. The comparison of patient characteristics, treatment and outcomes was hampered by heterogeneous recruitment settings.
引用
- Gisslander K, Rutherford M, Aslett L, et al. Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying. Ann Rheum Dis. 2024. PMID: 37907255. doi:10.1136/ard-2023-224571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。